If this sounds like you, this article is for you:

• You are consistent with treatment, but your hair loss or baldness still progresses.
• Minoxidil and/or finasteride helped at first, then results slowed or stopped.
• You have “dandruff” or scalp irritation that keeps coming back.
• A hair transplant result was disappointing, unpredictable, or did not last.

If you are doing “all the right things” for your androgenetic alopecia or pattern baldness, but results are stalling, read this.

Androgenetic alopecia (AGA), also known as male pattern baldness (MPB) or female pattern hair loss (FPHL), is common, visible, and emotionally heavy. Many patients do everything they are told: minoxidil, finasteride (or dutasteride), devices, shampoos, supplements, and still find that progress slows, stops, or becomes unpredictable.

When that happens, it is not always “bad luck,” and it is not always “you waited too long.”

The study titled “Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment – A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp” was published in the peer-reviewed Clinical Cosmetic and Investigational Dermatology journal. There, we describe a specific histologic pattern that can live quietly under the surface and help explain why some AGA and pattern baldness patients stop responding as expected, progress faster, or respond unpredictably to both medical therapy and hair restoration surgery.

It is called PIILIF, short for Perifollicular Infundibulo-Isthmic Lymphocytic Infiltrates and Fibrosis.

Quick takeaways

• PIILIF is a low-grade, immune-type inflammatory and early fibrotic pattern found around the upper portion of hair follicles (infundibulo-isthmic region) that can coexist with AGA and pattern baldness.
• It can be easy to miss clinically and can be mislabeled as “seb derm” or “just dandruff.”
• It may help explain why finasteride or minoxidil alone may not be enough for some people over time.
• It supports a dual-pathway strategy: address the hormonal pathway and the immune-fibrotic pathway, not one or the other.
• This is exactly why I created the Inflammatory AGA Screen Program (PIILIF Track).
• Important classification insight: the paper proposes that what has been described as fibrosing alopecia of patterned distribution (FAPD) aligns with a later stage of AGA-PIILIF, and recommends staging AGA-PIILIF by the degree of perifollicular fibrosis to support earlier recognition and intervention.

The missing link for AGA medication non-responders

This section is for the patient who is not planning surgery (or not yet), but is frustrated because the standard plan is not delivering what it should.

If the scalp environment is immunologically active and early fibrosis is already present, “more of the same AGA routine” is not always the answer.

The answer is:

• better biology control
• better targeting
• better timing

Here is the practical point

If PIILIF is present, “DHT control only” can leave a second driver running.

Standard AGA treatment often focuses on androgen signaling and follicle cycling support (for example, finasteride and minoxidil). That can be appropriate, but in a subset of patients, there is an additional layer: a perifollicular inflammatory and early fibrotic process that may continue even when DHT is addressed.

That is why some patients report:

• good early improvement, then slow decline again
• a stable period, then sudden acceleration
• “I’m consistent, but the response does not match the effort”

What this changes in real life

For the non-responder, the best move is not to guess harder.

It is to confirm what is actually happening in the scalp environment, and then treat the relevant pathways when indicated.

That does not mean every patient needs a biopsy.

It means:

• for non-responders, ambiguous cases, or high-stakes decisions, it is worth considering early diagnostic confirmation, not late.

What is PIILIF, in plain language?

PIILIF describes a subclinical perifollicular inflammatory pattern that concentrates around the upper follicle and is associated with early perifollicular fibrosis.

Key idea: it can be present even when the scalp looks “quiet,” and it can be present even in areas that are not yet visibly thinning or bald.

This matters because once fibrosis progresses, it can reduce the predictability of regrowth and restoration. That is why early recognition is the whole game.

Seeing PIILIF makes the concept clearer.
The short video below illustrates how PIILIF can exist beneath visible pattern baldness and why scalp biology matters when treatments or hair transplants stop responding.

Where FAPD fits: why this paper matters beyond “routine AGA”

If you have heard the term FAPD (fibrosing alopecia of patterned distribution), you already know it sits at the crossroads of two worlds:

• pattern hair loss that looks like AGA or male pattern baldness, and
• fibrosing/scarring biology that behaves more like early scarring alopecia

The key contribution of the paper is that it proposes a unifying framework:

• FAPD may represent a later, more fibrosing stage within the AGA-PIILIF spectrum, rather than a completely separate diagnosis.
• The paper recommends staging AGA-PIILIF by the degree of perifollicular fibrosis, which supports earlier recognition and more informed management decisions.

For patients, the takeaway is not to panic about “scarring.”
The takeaway is precision: if inflammatory and fibrotic drivers are present, it changes what “optimal care” looks like and why durability sometimes requires more than growth stimulation alone.

Why PIILIF gets mislabeled as seb derm or “just dandruff”

Many people with PIILIF report flaking, scale, or irritation. So it is easy to default to seborrheic dermatitis (“seb derm”) or “dandruff.” Whatsmore, the trichoscopic features of PIILIF may show similar findings associated with seborrheic dermatitis

But in our cohort, true seborrheic dermatitis on biopsy was rare compared with PIILIF.

Even when anti-dandruff shampoos temporarily improve scale or redness, that does not necessarily address the deeper perifollicular inflammatory process.

If you are treating “seb derm” aggressively and hair outcomes are still slipping, it is time to consider whether the label is wrong.

Why this matters for hair transplant planning

If the scalp environment is immunologically active and early fibrosis is already present, “more grafts” is not the answer.

The answer is:

• better biology control
• better planning
• better timing

In higher-risk candidates, pre-transplant control of PIILIF and biopsy-informed planning are advisable.

That does not mean every patient needs a biopsy. It means that for non-responders and high-stakes surgical candidates, diagnostic confirmation should be considered early rather than late.

Who should consider PIILIF screening?

You should at least consider PIILIF screening if you relate to one or more of these:

• You are not responding as expected to a well-run AGA regimen (meds, topical plan, lifestyle, compliance is solid).
• You have been told you have “seb derm” for years, but hair continues to miniaturize.
• You have advanced AGA or you are a complex case (including prior surgery, donor depletion, body hair follicular unit excision (FUE) or beard hair FUE reliance).
• You are planning a transplant and you want to reduce the risk of disappointing yield, ongoing thinning, or unpredictable healing.
• You are 44 years or older.
• You have perifollicular scale, redness, itch, tenderness, or shedding that does not match the clinical look of “routine AGA.”
• You developed overt features of scarring alopecia or severe inflammation after a hair transplant.

The Inflammatory AGA Screen Program (PIILIF Track)

I created this because too many complex patients with hair loss and baldness were being managed with a one-pathway playbook.

Program name: Inflammatory AGA Screen Program (PIILIF Track)
Format: Virtual first (with in-person follow up when needed)
Deposit: Required to protect quality, reduce no-shows, and allow proper time allocation

What the PIILIF Track helps us do

• Identify whether a patient’s AGA is likely “standard AGA” alone, or AGA plus PIILIF biology.
• Decide when a biopsy is appropriate and where it should be taken to improve diagnostic yield.
• Build a personalized plan aimed at:
  • controlling the inflammatory axis when indicated
  • reducing progression and improving durability
  • planning surgery only when the scalp biology is optimized

Long-Term Care Matters Long-term

Sustainable treatment matters because AGA‑PIILIF is a long game
When PIILIF is present, the goal is not a short burst of change. The goal is long-term stability of the scalp environment. PIILIF is best understood as a chronic, genetically influenced tendency toward follicle‑centered inflammation and early fibrosis that is not “cured” once and for all. It is managed. That reality changes how we choose treatments.

Control, not cure, means the plan must be livable for years
If control may need to be maintained for the long term, the foundation of care should be something a patient can realistically sustain. This argues against building the core plan around high‑burden or high‑risk approaches, especially because AGA‑PIILIF can be subtle compared with overt primary scarring alopecias. The biology may be meaningful even when the scalp looks “quiet,” but the management must remain practical and tolerable over time.

What we evaluated in our cohort
Because the working model involves long-term control, the study emphasized steroid-sparing options that may be suitable for longer-term use, with short-course therapies used selectively. Selections were informed by peer-reviewed literature on steroid-sparing management in primary cicatricial alopecias. Treatments used in the cohort, often in combination and individualized to the patient, included:

• Dutasteride and finasteride
• Oral minoxidil
• Topical calcineurin inhibitors
• Minocycline or doxycycline (typically as a time‑limited course)
• A selected phytoactive approach: Gashee topical and Gashee oral

What showed the clearest statistical signal in our analysis (and what did not)
In this retrospective cohort analysis, only some interventions showed a clear statistical association with improvement. In order of p‑value significance, the strongest signals in our dataset were observed with:

1. Topical and oral phytoactives (Gashee)
2. Topical calcineurin inhibitors
3. Minocycline
4. Dutasteride

Other treatments used in the cohort (including finasteride, oral minoxidil, and doxycycline) did not show the same level of statistical signal in this dataset. This may reflect sample size, duration, selection bias, combination regimens, dosing, or when and how an agent was deployed, rather than proving a treatment has no role.

The practical takeaway
The point is not that every patient needs every component. The point is that when AGA‑PIILIF biology may require long-term management, the strategy should prioritize approaches that are realistic to sustain, steroid‑sparing when appropriate, and matched to the level of inflammatory and fibrotic activity.

How this relates to Phytoactives
Within a long-term, steroid‑sparing framework, a phytoactive topical or oral option may be considered as supportive care as part of a broader plan, particularly when long‑term tolerability is a priority. In our cohort analysis, the use of Gashee in both topical and oral forms showed the strongest statistical signal among the steroid‑sparing measures evaluated, but this study is observational, and larger studies are needed to confirm and refine these findings. Gashee is not a substitute for diagnosis and is not positioned as a cure. It may be one tool within a clinician‑guided program when it fits the patient’s overall plan and risk profile.

Where a phytoactive product like Gashee fits (and where it does not)

Important points of clarification.

What Gashee is not

• It is not positioned as a “cure” for AGA, hair loss, or baldness.
• It is not a replacement for diagnosis.
• It is not a substitute for physician-directed therapy when stronger interventions are warranted.

Where Gashee can fit logically in the PIILIF conversation

PIILIF changes the strategy from “only push growth” to “optimize the scalp environment and protect follicle viability.”

Because AGA is a long-course condition, and because PIILIF (when present) can behave like a persistent, low-grade inflammatory process, long-term tolerability matters. That pushes smart clinicians toward steroid-sparing approaches whenever feasible.

In our PIILIF work, the practical takeaway is that some patients benefit when care includes scarring alopecia or PCA (primary cicatricial alopecia)-style anti-inflammatory and anti-fibrotic measures alongside appropriate androgen management.

In that context, phytoactive support can be part of a long-term maintenance philosophy, particularly for patients who need a plan they can sustain.

Gashee exists in both topical and oral forms. In my practice, when it is used, it is used as part of a broader plan, not as a standalone promise.

Important note: Gashee is designed to support the scalp environment as part of a broader hair loss program. It is not intended to diagnose, treat, cure, or prevent disease. Individual results vary.

The bigger point: stop guessing. Start staging.

If the biology is wrong, the plan will be wrong.

PIILIF gives us a clearer framework for:

• earlier detection
• better durability
• better surgical planning
• fewer “mystery non-responders”

If you are a patient who feels stuck, or a clinician managing difficult AGA cases, the PIILIF Track is built for you.

Next steps

Patients: Request a PIILIF Track evaluation
Start the PIILIF Track Intake

Clinicians: Refer a complex AGA case for PIILIF screening
Clinician Referral: PIILIF Track

Medical and product disclaimer

1. Gashee is designed to support the scalp environment as part of a broader hair loss program. It is not intended to diagnose, treat, cure, or prevent disease.
2. This article is for educational purposes and does not provide medical advice. Diagnosis and treatment should be individualized and guided by a qualified clinician. Product statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.

FREQUENTLY ASKED QUESTIONS

PIILIF, FAPD, treatment resistance, and what to do next

1) What is PIILIF?

PIILIF stands for Perifollicular Infundibulo-Isthmic Lymphocytic Infiltrates and Fibrosis. In plain terms, it describes a low-grade immune-type inflammation and early fibrotic change occurring around the upper portion of the hair follicle. It can coexist with androgenetic alopecia (AGA), also known as male pattern baldness or female pattern hair loss, and may be present even when the scalp looks “normal” on casual inspection.

2) Is PIILIF the same as FAPD?

Not exactly. FAPD (fibrosing alopecia of patterned distribution) is a term typically used when patterned hair loss shows a more advanced fibrosing or scarring-leaning biology. The key insight from this publication is that FAPD may align with a later stage within an AGA-PIILIF spectrum, rather than representing a completely separate condition.

From a practical standpoint, this means that earlier recognition of inflammatory and fibrotic drivers matters. Identifying AGA-PIILIF before extensive fibrosis develops allows clinicians to plan care with durability in mind, when the biology may still be more modifiable.

Waiting until the histologic features associated with FAPD are fully established may correspond to a more treatment-resistant stage. For this reason, the authors emphasize the value of recognizing and addressing AGA-PIILIF earlier, rather than deferring evaluation until later stages when fibrotic changes are more entrenched.

3) Do I need a biopsy to know if I have PIILIF?

Not everyone needs a biopsy. A biopsy becomes more relevant when your provider finds signs of inflammation on magnified (trichoscopic) examination of your scalp. The threshold is reduced if you are already a non-responder, your presentation is ambiguous, you have symptoms that do not fit “routine AGA” (itch, tenderness, burning, persistent scale), or you are making high-stakes decisions like hair transplant planning. The goal is not to biopsy everyone, it is to confirm scalp biology early when the stakes or uncertainty are high.

4) Why did my finasteride or minoxidil stop working?

There are several reasons treatments may stop working, and not all are about the medication itself. The main concept here is that AGA or pattern baldness is often treated as purely androgen-driven, but in a meaningful subset of patients an inflammatory and early fibrotic process may be operating in parallel. If that second driver is active, “more DHT control” alone may not fully stabilize the situation, which is why biology-aware evaluation and a dual-pathway strategy may be needed in selected cases.

5) Can PIILIF affect hair transplant outcomes?

It can. Hair transplantation is not just about graft numbers or technique, it is also about the health of the recipient scalp environment and long-term stability of surrounding native hair. If inflammatory-pattern biology and early fibrosis are active, predictability and durability can be affected, which is why scalp optimization and biopsy-informed planning can be important in higher-risk candidates.

6) What are phytoactives, and where do they fit in a long-term plan?

Phytoactives are plant-derived compounds that may support the scalp environment as part of a broader hair loss program. In a long-term maintenance context, many patients and clinicians prefer steroid-sparing approaches when appropriate, especially when scalp inflammation behaves as a chronic, low-grade process. In that framework, a phytoactive topical or oral product can be considered as supportive care, but it is not a replacement for diagnosis, and it should be used as part of a clinician-guided plan when stronger interventions are indicated.

7) Does PIILIF require lifelong treatment?
PIILIF, when present, may behave like a chronic, genetically influenced inflammatory tendency around hair follicles. The practical goal is long-term control and stability, not a one-time cure. Some patients may need ongoing maintenance for years, with the plan adjusted over time based on symptoms, exam findings, and overall risk profile under clinician guidance.

8) Do I need strong steroids or immunosuppressants to control PIILIF?
Not necessarily. AGA-PIILIF can be subtle compared with overt primary scarring alopecias, so aggressive therapy is not automatically the default. In our cohort, the emphasis was on steroid-sparing strategies that can be considered for longer-term use when clinically appropriate. Treatment choice and intensity should be individualized and supervised by a qualified clinician.

9) What kinds of long-term, steroid-sparing treatments were used in the study?
In this cohort, patients were managed with a steroid-sparing approach tailored to clinical context and often used in combination. Treatments used included dutasteride or finasteride, oral minoxidil, topical calcineurin inhibitors, and time-limited tetracyclines (such as minocycline or doxycycline). A selected phytoactive topical and oral option (Gashee) was also used as part of the broader scalp-care plan when appropriate.

In this retrospective dataset, the clearest statistical associations with improvement were observed in regimens that included: Gashee topical, Gashee oral, topical calcineurin inhibitors, minocycline, and dutasteride. Because many patients received combination regimens, these findings do not establish that any single component alone caused the observed outcomes. Observational findings do not prove cause and effect, larger studies are needed, and individual results vary. Gashee is not intended to diagnose, treat, cure, or prevent disease.

Important note: Products and supplements are not intended to diagnose, treat, cure, or prevent disease. Individual results vary, and medical decisions should be individualized with a qualified clinician.

The post Video: Read This If Your Hair Loss Treatment or Hair Transplant Has Stopped Working. What Science Shows appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

Scalp Micro-Pigmentation VS. Head Tattooing

While SMP and head tattooing may seem similar, they have different purposes and will give patients distinct results. Head tattooing employs traditional tattooing methods, and the results are more decorative and artistic than realistic. It employs standard tattoo ink applied deep into the dermis, and it could discolor to blue or green, migrate on the skin, and can be difficult to reverse without the use of laser tattoo removal.

Meanwhile, SMP is a clinical technique performed by trained practitioners to simulate the appearance of natural follicles. “We use specialized ink and a specialized technique,” said Dr. Umar. “Usually very superficial, to impact this look of scalp, creating the effect of stubble on the head in a pattern that mimics the natural distribution of hair.” Ultra-fine needles are used to deposit pigment into the upper dermis, resulting in a natural-looking hairline and density.

Why Patients Choose Head Tattoos

Many individuals seek head tattoos to reclaim confidence or camouflage balding. While the sentiment is valid, it’s important to distinguish between artistic intentions and clinical outcomes. SMP is tailored to restore the appearance of hair, not simply distract from its absence. Our patient Michael came into the Dr. U Hair and Skin Clinic seeking a procedure like this to achieve a fuller look while sporting a crew cut style. That’s when Dr. Umar suggested he get scalp micropigmentation (SMP) to complement his hair transplant results.

This technique is especially effective for:

• Camouflaging hair transplant scars
• Enhancing the appearance of hair density
• Refining hairlines after transplantation
• Creating a natural buzz-cut look

Patients like Michael demonstrate that hair restoration is not always about regrowth. Sometimes, it’s about recreating the illusion of density in a way that aligns with a patient’s lifestyle and appearance goals. SMP provides a subtle, impactful solution that empowers patients to wear shorter styles with confidence.

A Nonsurgical Approach To A Fuller Head Of Hair

SMP involves strategically tattooing pigment to the skin to create the appearance of stubble, making the scalp look fuller while softening harsh hairlines that were a result of hair transplants. In Michael’s case, it was used to disguise his strip hair transplant scar and give his buzzed hairdo a dense yet natural appearance. Because of his successful hair transplant with the Dr.UGraft® system, he was the ideal candidate for this procedure. “It’s the perfect use of SMP,” said Dr. Umar. “You have the hair, and then you just augment the density.” 

Subtle Yet Impactful Results Through SMP

Now, Michael can happily shave his head without worrying about bald patches and his previous scarring. The combination of FUE and SMP gave him realistic results, a softer hairline, and scalp density that he can be proud of. “I think this is the only combination of procedures that could’ve achieved this result from any doctor,” said Michael. “It looks so natural that nobody has commented on it.” These results fade gracefully within 18 to 24 months, and the procedure can be redone to achieve a fuller appearance of hair without the need for invasive surgeries.

Is Scalp Micropigmentation Right For You?

Follicular unit excisions have steadily grown in popularity, but many patients don’t realize that they have the option to complement their hair transplant results with SMP. As you have seen with our patient Michael, this procedure can render a realistic hairline and fullness that elevates your look, whether you’ve had hair transplantation surgery or not. To learn if scalp micropigmentation is right for you, book a free online consultation with Dr. Umar by filling up this form.

Individual results may vary. This story reflects one patient’s personal experience with scalp micropigmentation with Dr. Umar. Consult with a qualified physician for personalized advice.

Also available on Instagram Reels

Dr. U has helped even the most severely scarred patients find the relief they crave. To ask any questions you may have about hair restoration, you can submit them using the button below:

Free Hair Consultation

Further Reading:

1. https://dru.com/laser-tattoo-removal/
2. Umar Sanusi. Hair transplantation in patients with inadequate head donor supply using nonhead hair: report of 3 cases. Ann Plast Surg 2011; 67(4):322–5.
   https://pubmed.ncbi.nlm.nih.gov/21540728/

The post Video: Scalp Micropigmentation vs. Head Tattoo: Which Is Right for Your Hair Loss Journey? appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

Why Standard Tools Fail

Afro hair is tightly curled underneath the skin, and the follicles curve in a way that’s hard to see or follow with regular FUE tools. Most standard punches are straight and can’t adapt to this curvature, so they cut through the follicles instead of removing them intact. This is what’s called a transection, and it renders the graft unusable. When surgeons attempt FUE with these conventional devices, the results are often discouraging: high transection rates, poor graft survival, and patients left feeling hopeless about restoring their hair density.

Dr. Sanusi Umar’s Solution To Afro Texture FUE

Designed with inclusivity in mind, the Dr.UGraft Zeus system adapts intelligently to different hair and skin types, including tightly coiled, Afro-textured follicles, reducing the risks that have historically excluded these patients from FUE procedures

The device includes intelligent presets for:

• Afro-textured hair
• Straight or wavy hair
• Beard and body donor hair
• Long hair FUE

The system efficiently covers all FUE scenarios by providing adjustable torque, rotational speed, and movement dynamics. These work in tandem with an advanced hybrid smart punch to optimize follicle harvesting for different skin and hair types. Other standard devices don’t have these custom modes, and, combined with a sharp punch, they more often transect coiled Afro hair. The Dr.UGraft Zeus device is the only all-purpose device capable of performing FUE on textured hair, making it a particularly useful tool for African descent patients who want to undergo hair transplant surgery.

Watch the Dr. UGraft Zeus device in action in this Youtube Short:

POV: Afro beard hair, pulled to perfection by Dr. Umar #reels #shorts #asmr #satisfying # #DrU #hair

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

Also available on Instagram Reels

Proven Results Backed By Numbers

An independent study by Dr. Umar found that the Dr.UGraft Zeus device yielded consistent results across African descent patients who underwent FUE with it. Less than 10% of the follicular units extracted were broken and transected, whereas standard FUE tools with sharp punches can have a transection rate of up to 80% on coiled, Afro-texture hair.

An Inclusive Tool For All Hair Types

As the inventor of the Dr.UGraft® Zeus system, Dr. Umar has not only demonstrated his expertise in hair transplant surgeries, but he has also made the procedure more inclusive to traditionally underserved communities, particularly African descent patients, whose physical characteristics, heritage, and gene mixing have made them a particularly challenging group for FUE. By embracing the diversity of hair types, including those traditionally labeled “too difficult,” Dr. Umar has created a pathway for healing, confidence, and inclusion.

If you have Afro-textured hair and practitioners told you that hair transplants are not an option, it is time to explore the possibilities with Dr. UGraft Zeus. Fill out our online consultation form and discover a treatment designed for you.

Individual results may vary. This story reflects one patient’s personal experience with follicular unit extraction with Dr. Umar. Consult with a qualified physician for personalized advice.

The post Why Standard Hair Transplants Fail Afro Hair and How Dr. Umar’s Innovation Restores Hope appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

During a hair transplant, the practitioner takes grafts from a donor area, typically the back of the scalp. But what happens when this area has an insufficient number of hair follicles to harvest? This was the case for Jon, who wanted to overcome male pattern baldness while having a minimal donor supply to work with. After numerous failed transplants, he found Dr. Sanusi Umar, who used his expertise and cutting-edge tools to help Jon achieve a restored hairline and density.

When Traditional Hair Transplants Aren’t Enough

Our patient was desperate to bring back a full head of hair. He had undergone multiple hair transplant procedures that had failed, so his doctors referred him to Dr. Umar, an expert and innovator in follicular unit excision (FUE). Upon the first examination and testing, it was discovered that Jon suffered from perifollicular infundibulo-isthmic lymphocytic infiltrates and fibrosis (PIILIF). This inflammatory scarring condition attacks hair in an autoimmune fashion.

He likely had this undetected condition throughout his previous hair transplants, which is why each surgery resulted in suboptimal results. This left him still bald and with a depleted supply of donor hair from the sides and back of his head. Before even considering a hair transplant again, Jon was treated for the PIILIF, and Dr. Umar used his experience and technology to harvest donor grafts from elsewhere on the body.

Turning To Body Hair Transplantation

Despite the complexity of Jon’s case, Dr. Umar believed a solution was still possible. He proposed a unique approach: performing a FUE hair transplant using body hair from the beard and stomach.

FUE on regions other than the scalp poses its problems, which make hair more prone to transection:

• Hair grows at different angles
• Each strand can have its own unique texture and curl pattern
• Different areas of the body have different skin thickness

It’s limitations like this that influenced Dr. Umar to develop and invent the UGraft Zeus device.

UGraft Zeus: A Game-Changer in Body Hair Extraction

Unlike other FUE devices, the UGraft Zeus is an advanced, all-purpose FUE device that offers practitioners different modes and settings, depending on the area from which they are harvesting grafts. Each mode automatically adjusts torque, rotational speed, and movement dynamics to optimize follicle harvesting for different skin and hair types.

The device is also designed to promote optimal skin healing and minimize scarring due to:

• The punch shape, which dilates the skin rather than cutting a hole
• Fluid-assisted extraction, which reduces trauma
• The ability to adjust to different skin thickness
• The way it creates small, collapsible wounds that close faster

Jon’s Improved Hair Coverage Post-Surgery

Using the UGraft Zeus system, Dr. Umar was able to harvest grafts from Jon’s beard and stomach area, totalling about 12,000 grafts. Each graft was transplanted onto the scalp, and Jon now has improved hair density, length, and a newfound sense of confidence. The donor areas, as well, only have minimal scarring thanks to the UGraft Zeus system.

Now, Jon is satisfied with the results and happy about how Dr. Umar provided him one last shot at restoring his hairline, despite all the failed attempts that weighed on him. “I wanted to see what we could do,” he said. “And it’s been a remarkable transformation because I had very, very little hair on top.”

You Can Overcome Male Pattern Baldness, Too

If you’ve been told you’re not a candidate for hair restoration due to limited donor hair, previous transplant failures, or scarring, know that you still have options. At Dr. U Hair and Skin Clinic, we specialize in treating challenging cases using body hair transplantation, UGraft technology, and a deeply personalized approach. Like Jon and our other patients who have undergone hair transplant surgery, you can take the first step in your hair transplant journey by filling out our free online consultation form to be reviewed by Dr. Umar.

Watch the Jon’s transformation here:

Individual results may vary. This story reflects one patient’s personal experience undergoing follicular unit excision (FUE) with Dr. Umar. Consult with a qualified physician for personalized advice.

The post Video: After Failed Hair Transplants and No Donor Hair Left, Jon Found a Life-Changing Solution with Dr. Umar appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

One of the most commonly overlooked patterns I evaluate is PIILIF. The question matters because some patients continue to show redness long after hair transplant surgery, even when that redness has been assumed to be part of the normal healing process.

That assumption is exactly what led me to look more closely. Why do certain patients remain inflamed months after surgery while others do not? In some cases, we believe the answer may involve ongoing inflammation, a phenomenon we call PIILIF.

When Persistent Redness Deserves Another Look

For years, persistent redness after a hair transplant could be interpreted as simply part of healing. The short video asks viewers to reconsider that assumption when inflammation continues well beyond the expected recovery period described in the patient’s course.

PIILIF is the term I use for a pattern of ongoing inflammation that may be relevant in some of these cases. This does not mean that every patient with redness has the same explanation. Every patient should be evaluated individually, and the presence of persistent redness is a reason to ask questions rather than make assumptions.

Why PIILIF May Matter for Hair Transplant Healing

Understanding the biology behind persistent inflammation may help explain why healing and long-term results can differ from one person to another. That is the larger point of recognizing PIILIF: an outward sign that appears persistent may warrant a closer evaluation of what is happening in the scalp.

A Question Worth Evaluating

The practical takeaway is straightforward: persistent redness should not automatically be dismissed. If inflammation continues months after a hair transplant, the individual pattern deserves evaluation. PIILIF is one of the patterns I consider when asking why healing may be different from one patient to another.

Recognizing that possibility is not the same as making a diagnosis from appearance alone. It is an invitation to look more carefully at persistent inflammation and to evaluate each patient on their own clinical findings.

Watch the Short Video

Watch Dr. Sanusi Umar explain PIILIF and persistent redness after hair transplantation.

Take the Next Step

Explore the related PIILIF research page: PIILIF research and clinical context

Also available on Instagram and TikTok.

Medical disclaimer: This content is educational and not medical advice. Every patient should be evaluated individually.

Further Reading

1. https://dru.com/unveiling-a-shared-precursor-condition-for-acne-keloidalis-nuchae-and-primary-cicatricial-alopecias/
2. Umar S, Tan BH, Shitabata PK. Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment – A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp. Clin Cosmet Investig Dermatol. 2026;19:548520 https://doi.org/10.2147/CCID.S548520

The post Video: PIILIF: When Redness Persists After a Hair Transplant appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

“Severely bald?” That question opens Dr. Umar’s explanation. When male pattern baldness becomes advanced, the obvious assumption is that androgenetic alopecia, or AGA, has simply progressed further. The study discussed in the video suggests there may be another factor worth examining in some severe cases.

A Study Finding in Severe Male Pattern Baldness

Dr. Umar reports that PIILIF was more common in patients at Norwood level 5 or higher. He does not present that observation as proof that inflammation or fibrosis causes severe AGA. Instead, he frames it as a reason to ask whether those processes may be part of why some androgenetic hair loss becomes more severe.

The distinction matters. The short video is not arguing that every severe case has the same underlying biology. It is highlighting an association from the study and the clinical question that follows from it.

Look Beneath the Visible Bald Patch on Scalp

A visible bald patch on scalp may draw attention to the amount of hair that has been lost, but Dr. Umar’s message is to consider what may be happening beneath the surface. In the video, he specifically points to inflammation and fibrosis as possible contributors worth understanding in the context of severe AGA.

His practical takeaway is concise: “Understand your scalp biology.” The emphasis is on evaluation and on learning more about the condition before focusing only on additional growth.

Why Evaluation Comes Before Chasing More Growth

For someone thinking about more hair growth or repair hair transplant options, the video’s message is not to assume that severity tells the whole story. The supplied study finding raises a question about whether inflammation and fibrosis deserve attention in advanced cases, particularly at Norwood 5 and above.

This is an emerging research question, not a universal explanation for severe hair loss. As the accompanying caption stresses, evaluation matters and treatment should be individualized. The forward-looking point is simple: understanding scalp biology may help frame better questions before deciding what to pursue next.

Watch the Short Video

Watch on YouTube Shorts | Instagram | TikTok

Take the Next Step

Learn more: Restoring Hair With the uGraft Procedure

Medical disclaimer: This article is for educational purposes only and is not medical advice. Evaluation matters, and treatment should be individualized. The study finding discussed here does not establish that inflammation or fibrosis explains every case of severe androgenetic hair loss.

Further Reading

1. https://dru.com/piilif-in-dissecting-cellulitis-what-paired-biopsies-reveal-across-normal-appearing-scalp-quiet-nodules-and-active-lesionspiilif-in-dissecting-cellulitis/
2. Umar Sanusi. Hair transplantation in patients with inadequate head donor supply using nonhead hair: report of 3 cases. Ann Plast Surg 2011; 67(4):322–5.
   https://pubmed.ncbi.nlm.nih.gov/21540728/

The post Video: Male Pattern Baldness: Why Severe Hair Loss May Involve More Than AGA appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

“What treatment did you actually use?” That question is the starting point for Dr. Sanusi Umar’s explanation of the Two Marias. Both were treated for different forms of scarring hair loss, and their care was individualized rather than reduced to one universal treatment. The supplied account describes medical management, ongoing scalp maintenance, and hair transplantation when appropriate for each case.

Scarring Alopecia Care Went Beyond One Product

In the video, Dr. Umar says the Two Marias used GaSHEE products, but he immediately places those products within a broader treatment plan. He explains that some treatments were used for a period of time and then tapered, while scalp maintenance continued with GaSHEE tools. The emphasis is on how the pieces of care were used together, not on presenting one product as the entire answer.

Treatment was not approached as one size fits all. The stated goals were long-term scalp health, careful evaluation, and a plan matched to each diagnosis. For anyone seeking a medical evaluation for hair loss, the central message of this short is that similar-looking hair loss does not automatically mean identical care.

Hair Transplantation Was Part of the Individualized Plan

Dr. Umar also explains that both women underwent hair transplantation even though their conditions were different. In the case of Maria Landeros, he states that the transplant addressed the bald spot she had. The short does not present transplantation as an automatic step for every person with scarring alopecia. Instead, the accompanying caption specifies that transplantation was used when appropriate for the individual case.

Different Diagnoses Can Require Different Paths

The practical takeaway is not a formula. It is the need for individualized care. Scarring alopecia can appear similar from the outside, while the treatment path can differ from one patient to another. The Two Marias illustrate that distinction through plans that combined treatment, maintenance, and surgery according to their respective situations.

This is one patient experience, not medical advice. Results can vary, and treatment should be individualized.

Watch the Short Video

Watch Dr. Umar answer the treatment question: YouTube Shorts. You can also view the short on Instagram or TikTok.

Take the Next Step

View hair transplant patient results: Dr. U Hairline Transplant Results.

Medical disclaimer: This article is for educational purposes only and does not provide a diagnosis or individualized medical advice. Results can vary. Treatment decisions should be based on an appropriate clinical evaluation and individualized medical guidance.

Further Reading

1. https://dru.com/folliculitis-decalvans-maria-treatment-timeline/
2. Umar S.  and Carter M.A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation, Case Reports in Dermatological Medicine / 2021
   https://www.hindawi.com/journals/cridm/2021/6659943/

The post Video: Scarring Alopecia: Why Treatment Must Be Personalized appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

Treatment Started Before Hair Restoration

Dr. Umar makes the order of treatment the central point of the chapter. Maria had folliculitis decalvans, and the first step was not restoration. According to the video, the affected tissue was surgically excised before the scalp moved into the next stages of care.

Folliculitis decalvans is presented here as an inflammatory condition that can destroy follicles and lead to scarring alopecia. In Maria’s case, the sequence presented here is specific: removal of diseased tissue first, followed by stabilization of the scalp. That order is the key context for understanding how to treat folliculitis decalvans in this individual case.

Tattooing Came Before Transplantation

After the scalp was stabilized, tattooing was used to restore appearance during healing. The transplant came later. Dr. Umar states that Maria was the first to have her folliculitis decalvans surgically excised, tattooed, and then successfully transplanted three years later.

He also states that at that point there was “no evidence of the disease.” The chapter therefore presents the transplant as one part of a longer treatment sequence, not the starting point. It also avoids suggesting that restoration alone is one of the ways to protect remaining follicles without first considering the condition of the scalp.

From Procedures to Maintenance

The final stage described in the video is maintenance. Dr. Umar says Maria is now using topical botanicals that were given to her to help maintain her health. He summarizes the change simply: “She’s just living her normal life.”

For Maria, the story in this chapter is defined by timing and order: excision, stabilization, tattooing, transplantation three years later, and then maintenance. The next chapter will continue her Baldcast story.

Watch the Chapter

Watch Maria’s Baldcast chapter on YouTube

Take the Next Step

Watch on Instagram

Watch on TikTok

https://dru.com/refractory-folliculitis-decalvans-treatment-success-with-novel-surgical-excision-approach-a-breakthrough-case-series/

Medical disclaimer: This article describes one patient’s experience and is provided for educational purposes only. Individual circumstances and results vary. It is not a substitute for individualized medical advice.

Further Reading

1. https://dru.com/tufted-folliculitis-maria-care-moved-fast/
2. Umar S.  and Carter M.A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation, Case Reports in Dermatological Medicine / 2021
   https://www.hindawi.com/journals/cridm/2021/6659943/

The post Video: Folliculitis Decalvans: Maria’s Step-by-Step Treatment appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

A Thursday Meeting Maria Still Remembers

Maria begins with a small detail that stayed with her: “I remember it was a Thursday.” She recalls being told there was a doctor who could come see her. She did not know who he was at the time, but she said yes.

Then Dr. Umar walked in. Maria says she still remembers seeing him enter and offer her the opportunity to come to his clinic for a consultation. Her recollection gives this Baldcast chapter its center: not a long medical explanation, but the moment when access to care suddenly became immediate and personal.

From Consultation Offer to the Clinic by Monday

The pace changed quickly after that meeting. Maria says the clinic called her the same day. By Monday, she was in Dr. Umar’s office.

That sequence is central to how Maria tells the story. For someone seeking a dermatologist hair loss specialist, the chapter does not present a general roadmap or promise that care always moves this quickly. It simply documents Maria’s own experience and how rapidly the next steps came together after Dr. Umar offered the consultation.

By Friday, Maria Had Surgery

Maria finishes the timeline in one sentence: “And Friday I had the surgery.” The supplied chapter does not detail the operation, its technique, or its outcome, and it does not frame the procedure as a hair transplant. Instead, the focus remains on the speed with which Maria moved from meeting Dr. Umar to receiving surgical care.

The chapter ends before revealing what happened after surgery. That is the point of this part of Maria’s story: a Thursday introduction, a Monday clinic visit, and surgery on Friday. The full episode will continue the story and provide the next part of her experience.

Watch the Chapter

Watch Maria’s Baldcast chapter on YouTube

Take the Next Step

Watch on Instagram

Watch on TikTok

https://dru.com/hair-surgery-dr-ugraft-hair-transplant-repair-services/

Medical disclaimer: This article describes one patient’s experience and is provided for educational purposes only. Individual circumstances and results vary. It is not a substitute for individualized medical advice.

Further Reading

1. https://dru.com/hair-falling-out-maria-scalp-scarring/
2. Umar Sanusi. Hair transplantation in patients with inadequate head donor supply using nonhead hair: report of 3 cases. Ann Plast Surg 2011; 67(4):322–5.
   https://pubmed.ncbi.nlm.nih.gov/21540728/

The post Video: Tufted Folliculitis: When Maria’s Care Moved Fast appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.

A Father Shaves His Head So Mia Will Not Feel Alone

Mia’s father saw how she looked at other girls with hair and wanted hair like theirs. He decided to cut his own hair and shave his head so his daughter could see that she was not facing the experience by herself.

“I shaved my head so my daughter wouldn’t feel alone,” he explains in the video. He says he wanted Mia to be happy when she saw him and to recognize that he was also going through the process with her.

For him, the gesture was a way to help Mia feel less sad and more comfortable. The family’s story shows how a child’s hair loss can become an experience shared by the people closest to her.

Searching for Support and Signs of Hope

As Mia’s family searched for ways to support her, they chose to add Gashee, a botanical dietary supplement available through my clinic, to her daily routine. Over time, her family described seeing small signs that gave them hope and encouraged them to continue.

Her father describes the joy he feels seeing his daughter happy and says he is very happy to have found her doctor. He also expresses hope that other children and families facing hair loss can find help.

For families searching online for a hair regrowth treatment, the best hair loss treatment, or hair loss treatments that work, Mia’s experience should be understood as one family’s account, not a promise of what another person will experience. Individual experiences vary.

A Family Shares Its Experience

Mia’s story is ultimately about the support surrounding a child during a difficult period. Her father’s decision to shave his head was meant to help her feel that she was not alone, while the family continued seeking options and watching for encouraging changes.

They are sharing this part of their experience so another parent facing similar fears may feel less alone. For Mia’s family, the small signs they described were moments that encouraged them to keep going.

Watch the Short Video

Watch Mia’s short video on YouTube

Take the Next Step

Learn more about the related patient story and Gashee: Alopecia Totalis and Gashee Hair Growth Story

You can also view the story on Instagram or TikTok.

Medical Disclaimer

Gashee is a dietary supplement, not FDA approved, and not intended to diagnose, treat, cure, or prevent any disease. Individual experiences vary.

Further Reading

1. https://dru.com/hair-transplant-before-after-leg-hair-hairline-repair/
2. Umar S.  and Carter M.A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation, Case Reports in Dermatological Medicine / 2021
   https://www.hindawi.com/journals/cridm/2021/6659943/

The post Video: Mia’s Family Finds Hope While Seeking a Hair Regrowth Treatment appeared first on Dr. U Hair & Skin Clinic | FUE Hair Restoration, Dermatology and Laser Surgery | Los Angeles, Manhattan Beach | Dr Sanusi Umar MD.